Skip to main content
METABIOMED.CO.,LTD logo

METABIOMED.CO.,LTD — Investor Relations & Filings

Ticker · 059210 ISIN · KR7059210005 KO Manufacturing
Open in API
Filings indexed 217 across all filing types
Latest filing 2023-08-04 Transaction in Own Shar…
Country KR South Korea
Listing KO 059210

About METABIOMED.CO.,LTD

https://www.meta-biomed.com/

METABIOMED.CO.,LTD. is a developer and manufacturer of medical devices and biomaterials. The company's operations are organized into four primary business areas: Dental, Suture Material & Biomaterial, Meta Surgical, and Cosmetic Medical. Its dental division provides a range of equipment and materials, with its root canal filling product holding the largest global market share. The company also manufactures various synthetic absorbable surgical sutures, including Poliglecaprone (PGCL) and Polydioxanone (PDO) types. The surgical division offers devices for use in general surgery, orthopedics, neurosurgery, and obstetrics & gynecology. In the cosmetic medical field, it produces products such as PDO threads. METABIOMED distributes its products to over 100 countries through a global sales network.

Recent filings

Filing Released Lang Actions
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a formal regulatory filing titled '주요사항보고서(자기주식취득 신탁계약 체결 결정)' which translates to 'Report on Major Matters (Decision to enter into a treasury stock acquisition trust agreement)'. It details the extension of a share repurchase trust agreement, including specific financial data, contract dates, and board resolution details. This falls under the category of company share buyback or repurchase activities, which is classified as 'Transaction in Own Shares' (POS).
2023-08-04 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition and change in shareholding percentage by a major shareholder (Korea Securities Finance Corp) in Meta Biomed. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2023-07-10 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details the change in share ownership by Morgan Stanley & Co. International plc in Meta Biomed Co., Ltd. This document type is specifically designed to notify the market and regulators of significant changes in shareholding levels, which aligns with the 'Major Shareholding Notification' category.
2023-07-06 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and the Korea Exchange. It details the acquisition of shares by Morgan Stanley & Co. International plc in Meta Biomed Co., Ltd., crossing the 5% threshold. This type of filing is a standard regulatory requirement for major shareholders to disclose their ownership stakes and changes therein, which falls under the 'Major Shareholding Notification' category.
2023-06-12 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Meta Biomed Co., Ltd. for the first quarter of 2023 (제 25 기 1분기). It contains detailed financial data, business descriptions, and management information, which fits the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-05-15 Korean
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities regarding the extension of a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 연장결정). This type of filing specifically details the company's decision to buy back its own shares or manage existing treasury share trust contracts. According to the provided definitions, reports concerning the company buying back or selling its own shares are classified as 'Transaction in Own Shares' (POS).
2023-04-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.